Ownership history in ROYCE & ASSOCIATES LP · 28 quarters on record
This page tracks every 13F SEC filing in which ROYCE & ASSOCIATES LP reported a position in APYX MED CORP (APYX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 2,443,035 | -31,364 | -1.3% | 0.09% | $8.6M | $3.50 |
| 2025 Q3 | ADDED | 2,474,399 | +34,696 | +1.4% | 0.05% | $5.3M | $2.14 |
| 2025 Q2 | REDUCED | 2,439,703 | -85,764 | -3.4% | 0.06% | $5.5M | $2.25 |
| 2025 Q1 | REDUCED | 2,525,467 | -89,902 | -3.4% | 0.04% | $3.5M | $1.37 |
| 2024 Q4 | ADDED | 2,615,369 | +32,879 | +1.3% | 0.04% | $4.1M | $1.58 |
| 2024 Q3 | ADDED | 2,582,490 | +85,267 | +3.4% | 0.03% | $3.2M | $1.24 |
| 2024 Q2 | ADDED | 2,497,223 | +60,564 | +2.5% | 0.03% | $3.3M | $1.34 |
| 2024 Q1 | ADDED | 2,436,659 | +277,759 | +12.9% | 0.03% | $3.3M | $1.36 |
| 2023 Q4 | ADDED | 2,158,900 | +149,300 | +7.4% | 0.05% | $5.7M | $2.62 |
| 2023 Q3 | ADDED | 2,009,600 | +406,624 | +25.4% | 0.07% | $6.4M | $3.20 |
As of 2025 Q4 — sorted by position size